Related Experiment Video
Updated: Sep 27, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
[New inflammation modulator interleukins . Therapeutic implications]
Catălina Elena Lupuşoru1, Liliana Tarţău, Cristina Ghiciuc
1Diciplina de Farmacologie-Toxicologie-Algeziologie, Facultatea de Medicină, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi.
Abstract:
A lot of different leukocyte recruit soluble factors are implicated in both acute and chronic inflammatory processes with a higher expression of the cellular adhesion and chemoattraction molecules. Soluble factors implicated in these processes include: lipid inflammatory metabolites, arachydonic acid derivatives (prostaglandines, leucotrienes, lipoxines, PAF), the three soluble proteases waterfall events/substrates (coagulation, complement, kinines), nitric oxide, as well as cytokines implicated in acute or chronic inflammatory and cellular immune reactions. Recently, new inflammation modulator cytokines were described: IL-20, IL-21, IL-22 and IL-23. The aim of this work was to present some theoretical aspects regarding the biological effects of these new cytokines implicated in inflammation and the pharmacological influence of the processes mediated by them. Particularly IL-20 is implicated in psoriasis pathology. IL-21 and IL-15 are important in NK cells differentiation. IL-22 regulates the IL-4 production from Th2T cells. IL-23 stimulates IFN gamma production and proliferation in PHA blast T cells, as well as in CD45RO (memory) T cells.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Chronic Inflammation: Introduction